Position in IKT
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$32,266
+$6,164 QoQ
Shares Held
15,895
+2.3% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 105 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IKT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. IKT ranks #165 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,760 | $1,769,149 |
All Filings in IKT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,266 | 15,895 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $26,102 | 15,537 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $22,644 | 11,046 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $16,752 | 10,341 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $24,181 | 12,401 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||